Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation

FEBS Lett. 2022 May;596(9):1203-1213. doi: 10.1002/1873-3468.14354. Epub 2022 Apr 25.

Abstract

Nonstructural protein 1 (Nsp1) of SARS-CoV-2 inhibits host cell translation through an interaction between its C-terminal domain and the 40S ribosome. The N-terminal domain (NTD) of Nsp1 is a target of recurring deletions, some of which are associated with altered COVID-19 disease progression. Here, we characterize the efficiency of translational inhibition by clinically observed Nsp1 deletion variants. We show that a frequent deletion of residues 79-89 severely reduces the ability of Nsp1 to inhibit translation while not abrogating Nsp1 binding to the 40S. Notably, while the SARS-CoV-2 5' untranslated region enhances translation of mRNA, it does not protect from Nsp1-mediated inhibition. Finally, thermal stability measurements and structure predictions reveal a correlation between stability of the NTD and the efficiency of translation inhibition.

Keywords: COVID-19; Nsp1; SARS-CoV-2; pathogenicity; ribosome; virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / genetics
  • Humans
  • Protein Biosynthesis
  • Ribosomes / genetics
  • Ribosomes / metabolism
  • SARS-CoV-2* / genetics
  • Viral Nonstructural Proteins / metabolism

Substances

  • Viral Nonstructural Proteins